You are here

Foreign drug firms in China see approval delays

They worry that new procedures could push back plans to introduce medicines into the country by up to 2 years
Tuesday, December 9, 2014 - 05:50
4850868434343.jpg
Foreign pharmaceutical companies in China say they are concerned that recent regulatory delays could push back plans to introduce their newest medicines into the country by as many as two years.

Beijing

FOREIGN pharmaceutical companies in China say they are concerned that recent regulatory delays could push back plans to introduce their newest medicines into the country by as many as two years.

At least thirty-four applications from foreign multinationals have been or are